Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 183A (TMEM183A) is a protein-coding gene found on human chromosome 1. It is predicted to encode an integral membrane protein and is thought to be part of the SCF ubiquitin ligase complex, suggesting a possible role in the regulation of protein stability and ubiquitination pathways. The precise biological function is not fully characterized, and there are currently no known drug interactions, mechanisms of action, or established roles as a therapeutic target. Variants of this gene are associated with some diseases such as autosomal recessive deafness (DFNB63) and inflammatory bowel disease 7, but beyond genetic association, detailed mechanistic roles remain to be elucidated[1][4][6][12][14].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 183A (TMEM183A).